PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 12, 2022JAMA Neurology206 citationsOpen Access

Association of Amyloid Reduction After Donanemab Treatment With Tau Pathology and Clinical Outcomes

SSSergey ShcherbininCECynthia EvansMLMing‐Chi Lu

Key Points

Key points are not available for this paper at this time.

Abstract

ClinicalTrials.gov Identifier: NCT03367403.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Shcherbinin et al. (2022) studied this question.

synapsesocial.com/papers/69ded00f800448099bb0be6ahttps://doi.org/10.1001/jamaneurol.2022.2793
Ask AI
Helpful
Bookmark
Share
View Full Paper